Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab
| Autor: | Michel Clanet, Quentin Dardonville, Geneviève Durrieu, Jean-Louis Montastruc |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Pharmacology
medicine.medical_specialty business.industry Multiple sclerosis HPV infection medicine.disease 030226 pharmacology & pharmacy Dermatology 03 medical and health sciences 0302 clinical medicine Natalizumab Dysplasia medicine Pharmacology (medical) In patient business 030217 neurology & neurosurgery Adverse drug reaction medicine.drug |
| Zdroj: | Fundamental & Clinical Pharmacology. 33:125-126 |
| ISSN: | 0767-3981 |
| DOI: | 10.1111/fcp.12394 |
| Popis: | We describe one report of a cervical dysplasia in a patient receiving natalizumab for multiple sclerosis. Other cases were identified in the WHO's global individual case safety report database, VigiBase® . These data underline the importance of monitoring HPV infection in patients with MS treated with natalizumab. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text